Improving quality of life after breast cancer: a comparison of two microsurgical treatment options for breast cancer-related lymphedema (BCRL)

DiSipio T, Rye S, Newman B, Hayes S. “Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis,” (in eng). Lancet Oncol. 2013;14(6):500–15. https://doi.org/10.1016/S1470-2045(13)70076-7.

Article  PubMed  Google Scholar 

Vassard D, Olsen MH, Zinckernagel L, Vibe-Petersen J, Dalton SO, Johansen C. “Psychological consequences of lymphoedema associated with breast cancer: a prospective cohort study,” (in eng). Eur J Cancer. 2010;46(18):3211–8. https://doi.org/10.1016/j.ejca.2010.07.041.

Article  PubMed  Google Scholar 

Cidón EU, Perea C, López-Lara F. “Life after breast cancer: dealing with lymphoedema,” (in eng). Clin Med Insights Oncol. 2011;5:9–14. https://doi.org/10.4137/CMO.S6389.

Article  PubMed  PubMed Central  Google Scholar 

Taghian NR, Miller CL, Jammallo LS, O’Toole J, Skolny MN. “Lymphedema following breast cancer treatment and impact on quality of life: a review,” (in eng). Crit Rev Oncol Hematol. 2014;92(3):227–34. https://doi.org/10.1016/j.critrevonc.2014.06.004.

Article  PubMed  Google Scholar 

Smoot B, et al. “Upper extremity impairments in women with or without lymphedema following breast cancer treatment,” (in eng). J Cancer Surviv. 2010;4(2):167–78. https://doi.org/10.1007/s11764-010-0118-x.

Article  PubMed  PubMed Central  Google Scholar 

Ridner SH, Sinclair V, Deng J, Bonner CM, Kidd N, Dietrich MS. “Breast cancer survivors with lymphedema: glimpses of their daily lives,” (in eng). Clin J Oncol Nurs. 2012;16(6):609–14. https://doi.org/10.1188/12.Cjon.609-614.

Article  PubMed  Google Scholar 

Ridner SH, Bonner CM, Deng J, Sinclair VG. Voices from the shadows: living with lymphedema. Cancer Nurs. 2012;35(1):E18-26.

Article  PubMed  PubMed Central  Google Scholar 

Khan F, Amatya B, Pallant JF, Rajapaksa I. “Factors associated with long-term functional outcomes and psychological sequelae in women after breast cancer,” (in eng). Breast. 2012;21(3):314–20. https://doi.org/10.1016/j.breast.2012.01.013.

Article  PubMed  Google Scholar 

O’Toole J, et al. “Lymphedema following treatment for breast cancer: a new approach to an old problem,” (in eng). Crit Rev Oncol Hematol. 2013;88(2):437–46. https://doi.org/10.1016/j.critrevonc.2013.05.001.

Article  PubMed  PubMed Central  Google Scholar 

Ridner SH. “Quality of life and a symptom cluster associated with breast cancer treatment-related lymphedema,” (in eng). Support Care Cancer. 2005;13(11):904–11. https://doi.org/10.1007/s00520-005-0810-y.

Article  PubMed  Google Scholar 

Heinig B, Wollina U. “[Complex decongestive therapy],” (in ger). Hautarzt. 2015;66(11):810–8. https://doi.org/10.1007/s00105-015-3674-1.KomplexephysikalischeEntstauungstherapie.

Article  CAS  PubMed  Google Scholar 

Jeffs E, Ream E, Taylor C, Bick D. “Clinical effectiveness of decongestive treatments on excess arm volume and patient-centered outcomes in women with early breast cancer-related arm lymphedema: a systematic review,” (in eng). JBI Database Syst Rev Implement Rep. 2018;16(2):453–506. https://doi.org/10.11124/jbisrir-2016-003185.

Article  Google Scholar 

Jiang X, Nicolls MR, Tian W, Rockson SG. “Lymphatic dysfunction, leukotrienes, and lymphedema,” (in eng). Annu Rev Physiol. 2018;80:49–70. https://doi.org/10.1146/annurev-physiol-022516-034008.

Article  CAS  PubMed  Google Scholar 

Schaverien MV, Badash I, Patel KM, Selber JC, Cheng M-H. “Vascularized lymph node transfer for lymphedema,” (in eng). Semin Plast Surg. 2018;32(1):28–35. https://doi.org/10.1055/s-0038-1632401.

Article  PubMed  PubMed Central  Google Scholar 

Ozturk CN, et al. “Free vascularized lymph node transfer for treatment of lymphedema: a systematic evidence based review,” (in eng). J Plast Reconstr Aesthet Surg. 2016;69(9):1234–47. https://doi.org/10.1016/j.bjps.2016.06.022.

Article  PubMed  Google Scholar 

Ngo QD, et al. “Vascularized lymph node transfer for patients with breast cancer-related lymphedema can potentially reduce the burden of ongoing conservative management,” (in eng). Lymphat Res Biol. 2020;18(4):357–64. https://doi.org/10.1089/lrb.2019.0048.

Article  CAS  PubMed  Google Scholar 

Qiu SS, Pruimboom T, Cornelissen AJM, Schols RM, van Kuijk SMJ, van der Hulst R. “Outcomes following lymphaticovenous anastomosis (LVA) for 100 cases of lymphedema: results over 24-months follow-up,” (in eng). Breast Cancer Res Treat. 2020;184(1):173–83. https://doi.org/10.1007/s10549-020-05839-4.

Article  PubMed  PubMed Central  Google Scholar 

Cornelissen AJM, et al. “Effect of lymphaticovenous anastomosis in breast cancer-related lymphedema: a review of the literature,” (in eng). Lymphat Res Biol. 2018;16(5):426–34. https://doi.org/10.1089/lrb.2017.0067.

Article  PubMed  Google Scholar 

Wolfs J, de Joode L, van der Hulst R, Qiu SS. “Correlation between patency and clinical improvement after lymphaticovenous anastomosis (LVA) in breast cancer-related lymphedema: 12-month follow-up,” (in eng). Breast Cancer Res Treat. 2020;179(1):131–8. https://doi.org/10.1007/s10549-019-05450-2.

Article  PubMed  Google Scholar 

Coriddi M, Dayan J, Sobti N, Nash D, Goldberg J, Klassen A, Pusic A, Mehrara B. Systematic review of patient-reported outcomes following surgical treatment of lymphedema. Cancers. 2020;12(3):565. https://doi.org/10.3390/cancers12030565.

Article  PubMed  PubMed Central  Google Scholar 

Scaglioni MF, Fontein DBY, Arvanitakis M, Giovanoli P. “Systematic review of lymphovenous anastomosis (LVA) for the treatment of lymphedema,” (in eng). Microsurgery. 2017;37(8):947–53. https://doi.org/10.1002/micr.30246.

Article  PubMed  Google Scholar 

Rosian K, Stanak M. “Efficacy and safety assessment of lymphovenous anastomosis in patients with primary and secondary lymphoedema: a systematic review of prospective evidence,” (in eng). Microsurgery. 2019;39(8):763–72. https://doi.org/10.1002/micr.30514.

Article  PubMed  PubMed Central  Google Scholar 

Winters H, et al. “The efficacy of lymphaticovenular anastomosis in breast cancer-related lymphedema,” (in eng). Breast Cancer Res Treat. 2017;165(2):321–7. https://doi.org/10.1007/s10549-017-4335-0.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Scaglioni MF, Arvanitakis M, Chen YC, Giovanoli P, Chia-Shen Yang J, Chang EI. Comprehensive review of vascularized lymph node transfers for lymphedema: outcomes and complications. Microsurgery. 2018;38(2):222–9. https://doi.org/10.1002/micr.30079.

Article  PubMed  Google Scholar 

Ghazaleh AA, et al. “Combining reconstructive and ablative surgical treatment of chronic breast cancer-related lymphedema (BCRL): safe and effective,” (in eng). Breast Cancer Res Treat. 2023;197(1):83–92. https://doi.org/10.1007/s10549-022-06778-y.

Article  PubMed  Google Scholar 

Nielubowicz J, Olszewski W. “Surgical lymphaticovenous shunts in patients with secondary lymphoedema,” (in eng). Br J Surg. 1968;55(6):440–2. https://doi.org/10.1002/bjs.1800550609.

Article  CAS  PubMed  Google Scholar 

Hara H, Mihara M. “The accuracy of lymphatic ultrasound in measuring the lymphatic vessel size in lower limb lymphedema patients,” (in eng). J Plast Reconstr Aesthet Surg. 2022;75(5):1573–8. https://doi.org/10.1016/j.bjps.2021.11.104.

Article  PubMed  Google Scholar 

Yamamoto T, et al. “Technical pearls in lymphatic supermicrosurgery,” (in eng). Glob Health Med. 2020;2(1):29–32. https://doi.org/10.35772/ghm.2019.01010.

Article  PubMed  PubMed Central  Google Scholar 

E. C. o. t. I. S. o. Lymphology, "The diagnosis and treatment of peripheral lymphedema: 2020 Consensus Document of the International Society of Lymphology," (in eng), Lymphology, vol. 53, no. 1, pp. 3–19, 2020.

Lawenda BD, Mondry TE, Johnstone PA. “Lymphedema: a primer on the identification and management of a chronic condition in oncologic treatment,” (in eng). CA Cancer J Clin. 2009;59(1):8–24. https://doi.org/10.3322/caac.20001.

Article  PubMed  Google Scholar 

"The diagnosis and treatment of peripheral lymphedema: 2013 Consensus Document of the International Society of Lymphology," (in eng), Lymphology, vol. 46, no. 1, pp. 1–11, Mar 2013.

Clavien PA, et al. “The Clavien-Dindo classification of surgical complications: five-year experience,” (in eng). Ann Surg. 2009;250(2):187–96. https://doi.org/10.1097/SLA.0b013e3181b13ca2.

Article  PubMed  Google Scholar 

Ancukiewicz M, et al. “Comparison of relative versus absolute arm size change as criteria for quantifying breast cancer-related lymphedema: the flaws in current studies and need for universal methodology,” (in eng). Breast Cancer Res Treat. 2012;135(1):145–52. https://doi.org/10.1007/s10549-012-2111-8.

Article  PubMed  PubMed Central  Google Scholar 

Chang DW, Suami H, Skoracki R. “A prospective analysis of 100 consecutive lymphovenous bypass cases for treatment of extremity lymphedema,” (in eng). Plast Reconstr Surg. 2013;132(5):1305–14. https://doi.org/10.1097/PRS.0b013e3182a4d626.

Article  CAS  PubMed  Google Scholar 

Allen RJ, Cheng MH. “Lymphedema surgery: Patient selection and an overview of surgical techniques,” (in eng). J Surg Oncol. 2016;113(8):923–31. https://doi.org/10.1002/jso.24170.

Article  PubMed  Google Scholar 

Gasteratos K, Morsi-Yeroyannis A, Vlachopoulos NC, Spyropoulou GA, Del Corral G, Chaiyasate K. “Microsurgical techniques in the treatment of breast cancer-related lymphedema: a systematic review of efficacy and patient outcomes,” (in eng). Breast Cancer. 2021;28(5):1002–15. https://doi.org/10.1007/s12282-021-01274-5.

Article  PubMed 

留言 (0)

沒有登入
gif